Assessing Cancer Risk? Heres What the New DNA Test Can Do

A novel DNA test system that assesses a person’s genetic predisposition for certain cancers —the first of its kind granted marketing authorization by the US Food and Drug Administration (FDA) — may become a valuable new public health tool. The Common Hereditary Cancers Panel (Invitae Corp.) was approved late last month following FDA review under

NHS doctor faces calls to be SUSPENDED after mocking attacked Israelis

NHS doctor faces calls to be SUSPENDED for ‘sickening’ post that mocked innocent Israeli festivalgoers fleeing Hamas gunmen EXCL: Charity said the NHS should take action over the repugnant comments READ MORE: Who are Hamas? What you need to know about the terror group A doctor who mocked terrified Israelis fleeing Hamas gunmen is today facing calls to be

FDA Approves Intravenous Formulation of Secukinumab

The US Food and Drug Administration (FDA) has approved an intravenous (IV) formulation of secukinumab (Cosentyx) for the treatment of adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and nonradiographic axial spondyloarthritis (nr-axSpA).  Secukinumab is the only treatment approved in an IV formulation that specifically targets and blocks interleukin-17A and the only non–tumor necrosis factor

Is there an association between psoriasis onset and risk of autoimmune disease?

In a recent study published in the Scientific Reports Journal, researchers evaluated new-onset autoimmune disease risk among individuals with new-onset psoriatic illness. Study: Risk of incident autoimmune diseases in patients with newly diagnosed psoriatic disease: a nationwide population-based study. Image Credit: Flystock/Shutterstock.com Background Psoriatic illness, which frequently includes psoriasis and psoriatic arthritis, is a systemic inflammation-related disease

Precision medicine for gestational diabetes management

A recent Communications Medicine study has conducted two systematic reviews to determine precision markers to predict effective lifestyle and pharmacological interventions to manage Gestational Diabetes Mellitus (GDM). Study: Precision gestational diabetes treatment: a systematic review and meta-analyses. Image Credit: Photoroyalty/Shutterstock.com Background   GDM is a common pregnancy complication that poses short- and long-term risks to the mother

US drugmaker Bristol Myers Squibb buys Mirati for $4.8bn

US pharmaceutical company Bristol Myers Squibb announced a $4.8 billion deal on Sunday to acquire cancer drugmaker Mirati Therapeutics. Bristol Myers Squibb will pay $58 per share in cash “for a total equity value of $4.8 billion,” the companies said in a joint statement. In addition, a guaranteed value certificate (GVC) could provide Mirati shareholders

Medics clash over diabetes diagnoses for young women

Medics clash over diabetes diagnoses for young women after flawed tests lead to worries 35,000 patients have been wrongly given the all-clear Flawed diabetes tests mean 35,000 women may have wrongly had the all-clear Diabetes experts have clashed amid calls for a radical revamp on how younger women are tested for the disease. Top doctors

Could plant-based phytonutrients be the secret weapon against obesity?

A review article published in the journal Foods provides a detailed overview of the therapeutic effectiveness of phytonutrients in obesity. Background Obesity is a metabolic disease caused by complex interactions between genetic, environmental, and lifestyle factors. An individual with a body mass index (BMI) above 30 is considered obese. The prevalence of obesity is exponentially

Adverse Events Compared for Gout Flare Prophylactic Drugs

TOPLINE: Matched cohort studies revealed infrequent adverse events (AEs) with either treatment, but the number needed to harm for any AE was more than three times higher with colchicine vs NSAIDs. METHODOLOGY: The researchers conducted two matched retrospective cohort studies using the UK Clinical Practice Research Datalink and the Hospital Episode Statistics primary care datasets